Xylem INC Form 4 insider transactions

NYSE
Xylem Inc. Director Lisa Glatch filed a Form 4 indicating a pre-planned sale of 4,900 common shares at an average price of $140.6594, effective August 18, 2025.
NYSE
Xylem Inc. Director Victoria D. Harker sold 1,800 shares of common stock for approximately $143.63 per share under a pre-arranged trading plan.
NYSE
Xylem Inc.'s SVP & President, WSS, Rodney Aulick, reported a disposition of 1,665 shares of common stock valued at $126.24 per share to satisfy tax obligations related to the vesting of restricted stock units.
NYSE
Director Victoria D. Harker acquired 1,300 shares of Xylem Inc. common stock at $126.93 per share on May 13, 2025, increasing her total holdings to 20,375 shares.
NYSE
Director Lisa Glatch reports acquisition of 1,300 shares of Xylem Inc. common stock and now holds 10,064 shares.
NYSE
Director Uday Yadav reports the acquisition of 1,300 shares of Xylem Inc. common stock at a price of $126.93 per share.
NYSE
Director Mark D. Morelli reports acquiring 1,300 shares of Xylem Inc. common stock at $126.93 per share on May 13, 2025, along with holding 6,298 shares after the transaction.
NYSE
Director Lila Tretikov reports acquisition of 1,300 shares of Xylem Inc. common stock and ownership of 8,680 shares following the transaction.
NYSE
Director Jerome A. Peribere reports acquisition of 1,300 shares of Xylem Inc. common stock at $126.93 per share, along with holdings of 25,999 shares indirectly.
NYSE
Robert Friel, a director of Xylem Inc., reported the acquisition of 1,851 shares of common stock at a price of $126.93 per share on May 13, 2025, according to a Form 4 filing with the SEC.
NYSE
Director Earl R. Ellis reports acquisition of 1,300 shares of Xylem Inc. common stock through restricted stock units.
NYSE
Director Jeanne Beliveau-Dunn reports changes in beneficial ownership of Xylem Inc. securities.
NYSE
Dorothy Trefon Capers, SVP & General Counsel of Xylem Inc., filed a Form 4 disclosing changes in beneficial ownership of company securities.
NYSE
Xylem Inc. CEO Matthew Pine transferred 34,007 shares of common stock to the Matthew F. Pine and Angeles Lopez Guerrero Living Trust on March 11, 2025.
NYSE
Claudia S. Toussaint, SVP of Xylem Inc., transferred 6,197 shares of common stock to her revocable trust on March 10, 2025.
NYSE
Geri-Michelle McShane, VP, Controller & CAO of Xylem Inc., exercised stock options and sold shares on March 7, 2025.
NYSE
Hayati Yarkadas, SVP & President of Water Infrastructure at Xylem Inc., reports the acquisition of restricted stock units and non-qualified stock options.
NYSE
Rodney Aulick, SVP & President of Water Solutions and Services at Xylem Inc., reports the acquisition of restricted stock units and non-qualified stock options.
NYSE
William K. Grogan, SVP & Chief Financial Officer of Xylem Inc., reports the acquisition of restricted stock units and non-qualified stock options.
NYSE
Claudia S. Toussaint, SVP, CPSO of Xylem Inc., reports the acquisition of restricted stock units and non-qualified stock options.
NYSE
Geri-Michelle McShane, VP, Controller & CAO of Xylem Inc., reports the acquisition of restricted stock units and non-qualified stock options.
NYSE
Albert Cho, SVP of Strategy at Xylem Inc., reports the acquisition of restricted stock units and non-qualified stock options.
NYSE
Michael J. McGann, SVP & President of MCS at Xylem Inc., reports the acquisition of restricted stock units and non-qualified stock options.
NYSE
Matthew Pine, President and CEO of Xylem Inc., received an award of stock options and restricted stock units on March 5, 2025.
NYSE
Meredith Emmerich, SVP & President of AW at Xylem Inc., reports the acquisition of restricted stock units and non-qualified stock options.
NYSE
Dorothy Trefon Capers, SVP & General Counsel of Xylem Inc., reports the acquisition and disposal of common stock and derivative securities, including stock options, on March 4th and 5th, 2025.
NYSE
Hayati Yarkadas, SVP & President of EU, WI & GLS at Xylem Inc., reports the acquisition and disposal of common stock related to the vesting of performance-based stock units and tax liability payments.
NYSE
Geri-Michelle McShane, VP, Controller & CAO of Xylem Inc., reports acquisition and disposal of common stock related to vesting of performance-based stock units and tax liability coverage.
NYSE
Albert Cho, SVP of Strategy at Xylem Inc., reports the acquisition and disposal of common stock related to the vesting of performance-based stock units and tax liability payments.
NYSE
Dorothy Trefon Capers, SVP & General Counsel of Xylem Inc., reports the acquisition and disposal of common stock related to vesting of performance-based stock units and tax liability payments.